232 related articles for article (PubMed ID: 28390297)
1. The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer.
Kosmin M; Makris A; Joshi PV; Ah-See ML; Woolf D; Padhani AR
Eur J Cancer; 2017 May; 77():109-116. PubMed ID: 28390297
[TBL] [Abstract][Full Text] [Related]
2. The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
Zugni F; Ruju F; Pricolo P; Alessi S; Iorfida M; Colleoni MA; Bellomi M; Petralia G
PLoS One; 2018; 13(10):e0205251. PubMed ID: 30312335
[TBL] [Abstract][Full Text] [Related]
3. Patterns of disease progression in patients with local and metastatic breast cancer as evaluated by whole-body magnetic resonance imaging.
Kosmin M; Padhani AR; Sokhi H; Thijssen T; Makris A
Breast; 2018 Aug; 40():82-84. PubMed ID: 29709728
[TBL] [Abstract][Full Text] [Related]
4. Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Bhaludin BN; Tunariu N; Senthivel N; Babiker A; Soneji ND; Hujairi N; Sharma B; McGrath SE; Okines AF; Ring AE; Messiou C; Downey K; Koh DM
Cancer Imaging; 2022 Jun; 22(1):26. PubMed ID: 35672838
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
Kosmin M; Padhani AR; Gogbashian A; Woolf D; Ah-See ML; Ostler P; Sutherland S; Miles D; Noble J; Koh DM; Marshall A; Dunn J; Makris A
Radiology; 2020 Dec; 297(3):622-629. PubMed ID: 33078998
[TBL] [Abstract][Full Text] [Related]
7. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
Taylor SA; Mallett S; Ball S; Beare S; Bhatnagar G; Bhowmik A; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Lock S; Miles A; Morris S; Morton A; Navani N; Oliver A; O'Shaughnessy T; Padhani AR; Prezzi D; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Russell P; Sidhu HS; Strickland N; Tarver K; Teague J; Halligan S;
Lancet Respir Med; 2019 Jun; 7(6):523-532. PubMed ID: 31080129
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
[TBL] [Abstract][Full Text] [Related]
10. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
11. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
[TBL] [Abstract][Full Text] [Related]
13. Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study.
Buus TW; Rasmussen F; Nellemann HM; Løgager V; Jensen AB; Hauerslev KR; Christiansen P; Pedersen EM
Eur Radiol; 2021 Dec; 31(12):8838-8849. PubMed ID: 34008104
[TBL] [Abstract][Full Text] [Related]
14. [Whole-body MRI in preoperative diagnostics of breast cancer--a comparison with [corrected] staging methods according to the S 3 guidelines].
Hausmann D; Kern C; Schröder MT; Sütterlin M; Schönberg SO; Neff KW; Dinter DJ
Rofo; 2011 Dec; 183(12):1130-7. PubMed ID: 22068844
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
16. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
17. Application of whole-body MRI to detect the recurrence of lung cancer.
Lee MH; Kim SR; Park SY; Park SJ; Lee EJ; Jin GY; Lee YC
Magn Reson Imaging; 2012 Dec; 30(10):1439-45. PubMed ID: 22817957
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
Li B; Li Q; Nie W; Liu S
Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
[TBL] [Abstract][Full Text] [Related]
20. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
